Show
Sort by
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
-
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes
-
Hereditary prostate cancer : primetime for genetic testing?
-
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
-
Sclerosing bone dysplasias : leads toward novel osteoporosis treatments
-
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
-
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
-
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
-
Leiden open variation database of the MUTYH gene